हिन्दी Blogs
Menu

Latest Posts
A vote for NDA is a vote for Bihar’s stability and prosperity: PMPrime Minister interacts with ICC Women’s World Cup 2025 championsIndia emerges as a global torchbearer linking economic growth with environmental sustainability: Dr. Jitendra SinghBihar has moved from the era of lanterns to the era of LEDs: Jagat Prakash NaddaPM congratulates Amul and IFFCO for securing the 1st and 2nd ranks in the global ranking for cooperatives

Jan Aushadhi Kendras quality medicines at 50% to 80% lower rates

| Published on:

The National Pharmaceutical Pricing Authority (NPPA) under the Department of Pharmaceuticals (DoP) fixes ceiling prices of scheduled medicines in accordance with the provisions of DPCO, 2013. All manufacturers and marketers of scheduled medicines are required to sell their products within the ceiling price (plus applicable Goods and Service Tax) fixed by the NPPA. Further, NPPA fixes the retail price of new drugs, as defined in DPCO, 2013. For applicant manufacturers and their marketers, who too are required to sell the new drug within the price notified by NPPA. In respect of non-scheduled formulations, manufacturers are required to not increase the Maximum Retail Price of the drugs launched by them by more than 10% during the preceding 12 months. As on 12.3.2025, ceiling prices of 928 scheduled formulations and retail prices of over 3,200 new drugs stood fixed by NPPA. Details of prices fixed by NPPA are available on its website (www.nppaindia.nic.in ).